Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine in children and adolescents 6 months through 17 years of age in India

Efficacy and safety data on quadrivalent influenza vaccines (QIVs) for immunization of Indian children are scarce. This phase 3, registration study evaluated the immunogenicity, safety, and tolerability of a QIV in Indian children aged 6–35 months (Group 1) and 3–17 y (Group 2). Subjects received on...

Descripción completa

Detalles Bibliográficos
Autores principales: Kalappanavar, Nijalingappa K., Ghosh, Apurba, Sharma, Monika, Ravichandran, Latha, Choraria, Nirmal, P, Saravanan, Pandey, Madhukar, N, Pradeep, Shah, Prachee, Nair, Sneha, Shaikh, Ashfaque, van de Witte, Serge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Influenza – Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746468/
https://www.ncbi.nlm.nih.gov/pubmed/36053721
http://dx.doi.org/10.1080/21645515.2022.2104527

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746468/
https://www.ncbi.nlm.nih.gov/pubmed/36053721
http://dx.doi.org/10.1080/21645515.2022.2104527

Ejemplares similares